Skip to content

Clinical trials

Leukemia-Lymphoma, Adult T-Cell trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia-Lymphoma, Adult T-Cell Country / region: Japan Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20102
20121
20161
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kyowa Kirin Co., Ltd.3
Celgene2
Bristol-Myers Squibb1
Daiichi Sankyo Co., Ltd.1
Japan Clinical Oncology Group1
Novartis Pharmaceuticals1
SymBio Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia-Lymphoma, Adult T-Cell10
Lymphoma4
Lymphoma, T-Cell, Peripheral4
Immunoblastic Lymphadenopathy2
Lymphoma, Large-Cell, Anaplastic2
Lymphoma, T-Cell2
Lymphoma, T-Cell, Cutaneous2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma2
Recurrence2
Epstein-Barr Virus Infections1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.